On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayJun 14, 2017 9:25 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Targets Canadian Cannabis Market by Incorporating CBD Biotechnology Inc. in British Columbia

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. “I am delighted about the incorporation of CBD Biotechnology Inc.,” Warren Wang, founder and CEO of CIIX, stated in the news release. “The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX's goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health.” Canada promises to play a major role…

Continue Reading

TuesdayJun 13, 2017 9:00 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Teams with Pharmaseed to Advance Development of INM-750

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into an agreement with Pharmaseed Ltd., Israel’s largest GLP-certified pre-clinical contract research organization. Under the terms of this agreement, the Pharmaseed development team will now play a key role in the ongoing development of InMed’s lead compound, INM-750, which is a proprietary, topical cannabinoid product candidate that’s currently being studied as a therapy in epidermolysis bullosa and other potential dermatological and wound-healing applications. “This agreement with Pharmaseed now adds one of Israel's leading formulation development teams to our efforts and represents an important strategic…

Continue Reading

MondayJun 12, 2017 8:55 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Becomes Exclusive Licensee of Cannabis-Based Treatment for Alzheimer’s Disease

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its entry into a definitive license agreement with the University of South Florida that makes the company the exclusive licensee of the U.S. patent filing entitled ‘THC as a Potential Therapeutic Agent for Alzheimer’s Disease’. If the patent filing is granted and proven, IGC anticipates that it could create a “significant therapeutic pathway” in the Alzheimer’s disease market, which is expected to record direct costs in excess of $450 billion annually in the next 12 years. “Securing this…

Continue Reading

TuesdayJun 06, 2017 9:27 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Teams with First Bitcoin Capital (BITCF) to Develop Bitcoin Payments Solution

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced an initiative to develop a bitcoin payments solution in partnership with First Bitcoin Capital Corp. (OTC: BITCF), an industry-leading bitcoin and blockchain technology provider. Per the news release, the two companies have signed a joint venture agreement to develop and distribute a viable payments solution targeted at “high-risk payment verticals including the cannabis industry” in order to “fill the payments gap that currently exists.” Through this new partnership, SinglePoint and First Bitcoin Capital intend to focus on their respective core strengths in order to build and supply the best bitcoin…

Continue Reading

FridayJun 02, 2017 9:39 am

NetworkNewsBreak – Player’s Network, Inc. (PNTV) Completes First Phase of Construction for Green Leaf Farms Cultivation and Production Facility

Player’s Network, Inc. (OTCQB: PNTV) this morning announced the completion of the the first phase of its 27,000-sq.-ft. facility being built in North Las Vegas for its subsidiary Green Leak Farms Holdings. mCig, Inc. (OTCQB: MCIG), the company contracted to develop and build out the facility, worked with the City of North Las Vegas and the State of Nevada to ensure Green Leaf was 100% compliant. The first phase included two vegetation and flower rooms, an extraction lab and all the needed infrastructure to support the facility. According to the press release, phase 2 and phase 3 are nearing completion…

Continue Reading

WednesdayMay 31, 2017 10:55 am

CannabisNewsBreaks – Cannabis Wheaton (TSXV: CBW) to Invest $30M in ABcann Global Corporation (TSXV: ABCN) for Construction of Additional Cannabis Cultivation Facility

Medical cannabis grower ABcann Global (TSXV: ABCN) is set to receive an investment of $30 million from Cannabis Wheaton Income (TSXV: CBW) for the funding of a 50,000-square-foot cultivation space at ABcann’s proposed facility to be located in Napanee, Ontario. Per a binding interim agreement announced earlier this week, Cannabis Wheaton’s investment will fund the construction of an “expansion production area” that is in addition to ABcann’s 100,000-square foot-facility, which is expected to commence construction “imminently.” Cannabis Wheaton will receive 50% of the proceeds (net of certain costs) of future wholesale or retail sales completed by ABcann with respect to…

Continue Reading

WednesdayMay 24, 2017 10:38 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Completes Acquisition of Discount Indoor Garden Supply

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced the completion of its acquisition of Discount Indoor Garden Supply (“DIGS”). Under the terms of the agreement, SinglePoint has acquired a 90 percent stake in DIGS through a stock and cash transaction, further demonstrating the company’s ability to strategically expand its portfolio of investments in established, high-potential cannabis businesses. “This acquisition is an important one for SinglePoint and strengthens our footing in the cannabis industry,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “The acquisition of DIGS is phenomenal for the company's books. More importantly though are the…

Continue Reading

WednesdayMay 17, 2017 10:09 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Enters Letter of Intent to Acquire Stake in Discount Indoor Garden Supply

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its entry into a Letter of Intent with Discount Indoor Garden Supply (“DIGS”). Per the terms of the LOI, SinglePoint will acquire 90 percent of DIGS in a stock and cash transaction. The company anticipates that the acquisition will bring immediate revenues to SinglePoint while positioning it as a leader in online products, retail stores, cannabis consulting and equipment in California. “We are committed to identifying and making investments that will strengthen both parties' position in the cannabis industry while building SinglePoint's corporate value,” Greg Lambrecht, CEO of SinglePoint, stated…

Continue Reading

TuesdayMay 16, 2017 10:37 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Adds Craig Cheifetz, M.D. to Advisory Team

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that Craig Cheifetz, M.D. has joined the company as an advisor to provide guidance on clinical trials, biotechnology, neuroscience, immunology and microbiology. “I welcome Dr. Cheifetz to the IGC advisory team and look forward to his contributions as we move forward in developing cannabis-based, combination therapies,” Ram Mukunda, CEO of IGC, stated in the news release. “We remain committed to accelerating our initiatives and building a robust portfolio of compounds to address large market conditions.” Cheifetz currently serves…

Continue Reading

WednesdayMay 10, 2017 1:58 pm

CannabisNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Extends Role of “Father of Marijuana Research” Raphael Mechoulam

In a news release issued early Tuesday, ABcann Global Corporation (TSXV: ABCN) announced that Raphael Mechoulam has agreed to extend his role as an advisor to the company. Aaron Keay, CEO and director of ABcann, spoke to the importance of this agreement in the news release. “Professor Mechoulam’s experience in medicinal cannabis is an invaluable resource for ABcann as we enter the most aggressive growth stage in the company’s history,” he stated. “The Company has invested heavily to build and extend its early leadership in advanced pharmaceutical-grade cannabis production. Professor Mechoulam’s advice, guidance, and unmatched expertise in the field has…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722